giotrif
boehringer ingelheim international gmbh - afatinib - Карцином, недребноклетъчен белодроб - Антинеопластични средства - giotrif като монотерапии, предназначени за лечение на ofepidermal приемащото устройство фактор на растежа (РЭФР) tgc-наивни възрастни пациенти с локално-напреднал или метастазирал немелкоклеточным рак на белите дробове (НМРЛ) с активирующей мутации РЭФР (- и);локално-напреднал или метастазирал НМРЛ плоскоклетъчен хистология прогресира или след химиотерапия платиносодержащей.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - Карцином, недребноклетъчен белодроб - Антинеопластични средства - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
imatinib krka 400 mg film - coated tablets
krka, d.d. novo mesto - 400 mg film - coated tablets
imatinib krka 100 mg film - coated tablets
krka, d.d. novo mesto - 100 mg film - coated tablets
imatinib synthon 100 mg film - coated tablets
synthon bv - 100 mg film - coated tablets
imatinib synthon 400 mg film - coated tablets
synthon bv - 400 mg film - coated tablets
imatinib bioorganics 100 mg film - coated tablets
bioorganics bv - 100 mg film - coated tablets
imatinib bioorganics 400 mg film - coated tablets
bioorganics bv - 400 mg film - coated tablets
imatinib glenmark loomg film - coated tablet
glenmark pharmaceuticals s.r.o., - loomg film - coated tablet
imatinib glenmark 400mg film - coated tablet
glenmark pharmaceuticals s.r.o., - 400mg film - coated tablet